Two Years ago we moved to NJ!

While we celebrate our 10th anniversary as a company in 2016 – we also celebrate our 2 year “move to NJ” anniversary this month.  Seems like only months ago we moved to Princeton Corporate Center in Ewing NJ from Newtown, PA.  So much has happened – time has flown by.  We are thrilled to be a thriving company in a dog eat dog world!  Our employees are the world to us – we hope they continue to be happy being part of the “Essential Family” http://princetoninfo.com/index.php/component/us1more/?Itemid=6&key=5-14-14essential  
Continue

Essential Pharmaceuticals launches new streamlined website & online ordering system for bioproduction and research products

EWING, N.J., May 10, 2016 /PRNewswire/ — Essential Pharmaceuticals, LLC has launched a new website for Cell-Ess®specifically focused on content relevant to large scale bioproduction of proteins. Concurrently, Essential launched a new online ordering system for Cell-Ess and Clin-Ess® transportation media. Cell-Ess is a chemically-defined and animal component free medium that can be added as a supplement or feed in a bioreactor to increase cell productivity. Clin-Ess is a chemically-defined tissue transport medium that doesn’t contain serum or other toxic preservatives. http://www.prnewswire.com/news-releases/essential-pharmaceuticals-llc-launches-new-streamlined-website-and-online-ordering-system-for-bioproduction-and-research-products-300265289.html?tc=eml_cleartime  
Continue

Supporting the Cleveland Clinic Pedalers Team!!!

VeloSano is a unique event with the goal of bringing an entire community together to help one another.  We are  supporting the mission of VeloSano and Dr. John Fung to help to raise money for the cause.  100% of the money they raise will support lifesaving cancer research at Cleveland Clinic.  The goal is to bring sustainable funding to cancer research by enlisting the passion and energy of thousands of people who wish to give back…including YOU!   John Fung Rider: 50-mile Challenge Team: Cleveland Clinic: Pepsin Pedalers View Team Join me to support DDI http://ccf.convio.net/site/TR/VeloSano/General?px=2489502&pg=personal&fr_id=1651
Continue

Great Talks, Posters and Entertainment at Peptalk 2016

As usual, this year’s Peptalk did not disappoint.  Held in San Diego from January 18th-22nd, Peptalk (The Protein Science Week) featured interesting talks and posters as well as entertaining events for attendees.  A couple highlights of the week: Dr. Nathan Lewis of UCSD discussed a systems biology approach to understand CHO cells and use that information to improve the efficiency of CHO cell factories A panel discussion including Dr. Lewis and Dr. Sarah Rue of Novartis explored what drives bioproduction engineers to innovate, why the industry hasn’t moved away from CHO to human cell lines, and the future of regulation,
Continue

Story on Essential Pharmaceuticals in the Yahoo Finance section!!!

http://finance.yahoo.com/news/essential-pharmaceuticals-releases-data-bioproduction-161400002.html WING, N.J., Jan. 13, 2016 /PRNewswire/ — Essential Pharmaceuticals, LLC releases new data on bioproduction scalability using Cell-Ess® media supplement.  Cell-Ess, a chemically-defined and animal component free supplement, delivers critical components needed for cell growth.  Cell-Ess can be used as a building block to create robust media to address the cell culture demands of bioproduction.  Scalable protein biomanufacturing was boosted by the addition of this novel supplement to a previously optimized CHO serum-free media….http://finance.yahoo.com/news/essential-pharmaceuticals-releases-data-bioproduction-161400002.html
Continue

Essential Gives back – again

December 2015 –Essential Pharmaceuticals LLC, conducted a toy drive for the pediatric patients at Bristol Meyers Squib Children’s Hospital. This is the third year Essential has conducted this toy drive and to date has been the most successful. Donating over 200 toys from employees of Essential Pharma, colleagues and co-workers, the children at BMS Children’s Hospital had much to be excited about of Christmas Eve. A representative from the hospital stated to Denise Weber (Director of Corporate Operations for Essential) – “This is largest toy donation we have received. You have no idea how delighted these children (and staff) will
Continue

Brand Genius – Associate Product Manager/Product Manager needed

Are you a Marketing guru who understands what it takes to stand apart in the field of life-sciences and bio-pharmaceutical production? Are you a creative thinker, designer and implementer that can spread the word of our solutions to both customers and our sales team? A unique position has been created for you! We are taking both our Medical Division and Research Division and placing them under one umbrella for this position. You’ll work with our Managers and Sales Team(s) to provide educational and promotional materials to research labs, bio-pharmaceutical companies, hospitals, and surgeon’s. Your primary focus will be in the
Continue

Increasing Protein Production with Novel Cell-Ess Supplement without Affecting Metabolic Profile; a presentation that will be given at the upcoming BioProcessing Summit

At this years, always popular and always educational, BioProcessing Summit Meeting in Boston at the Westin Copley Place on August 5th, Adam Elhofy (PhD and CSO of Essential Pharmaceuticals) will be presenting on the topic of  Increasing Protein Production with Novel Cell Ess Supplement without Affecting Metabolic Profile. http://www.bioprocessingsummit.com/bioproduction “Enhancing protein production is a common goal in the bio-manufacturing industry. At a concentration of 1% Cell Ess supplement resulted in a 37% increase in productivity. When using the supplement as a feed it resulted in in a 25% increase in yield and an extension of peak protein production. Our results
Continue

The Economics of Reproducibility in Preclinical Research

We stumbled across an interesting paper by Leonard P. Freedman, Iain M. Cockburn, Timothy S. Simcoe Global Biological Standards Institute, Washington, D.C., United States of America, 2Boston University School of Management, Boston, Massachusetts, United States of America, Council of Economic Advisers, Washington, D.C., United States of America “Low reproducibility rates within life science research undermine cumulative knowledge production and contribute to both delays and costs of therapeutic drug development. An analysis of past studies indicates that the cumulative (total) prevalence of irreproducible preclinical research exceeds 50%, resulting in approximately US$28,000,000,000 (US $28B)/year spent on preclinical research that is not reproducible—in
Continue

Comparable outcome of liver transplantation with Histidine-Tryptophan-Ketoglutarate vs. University of Wisconsin preservation solution: a retrospective observational double-center trial

Background                                                      The question of whether the choice of preservation solution affects outcome after liver transplantation is still not satisfactorily answered. The purpose of this study is to examine the preservation solutions? impact on outcome after liver transplantation. Methods A double-center retrospective study of short- and long-term results of 3134 consecutive liver transplantations with follow-up periods up to 23 years was performed applying multivariate, risk-adjusted analyses with a subset for living-donor transplants, pediatric transplants and cases with prolonged cold ischemic times. An additional focus was put on biliary complications. The primary study endpoints were short- and long-term patient survival and death-censored
Continue

Transplantation of a horseshoe kidney from a living donor: Case report, long term outcome and donor safety

The use of a horseshoe kidney in renal transplant remains controversial, when it is found in the evaluation of a living donor, anatomical, surgical and ethical issues are involved. A 51 year old woman was considered as a kidney donor to her 30 year-old son. Recipient was transplanted 11 years before with his father’s right kidney and implanted in the left side of the lower abdomen. After 10 years of adequate renal function, he developed chronic rejection and returned to hemodialysis. A new transplant was proposed and the mother was found to be the only available donor. Mother’s preoperative study
Continue